TrialFrontiers in cellular and infection microbiology2026
Gut microbial dynamics and antibiotic resistance during rifaximin therapy in severe cirrhosis: a ProPILA-Rifax ancillary study.
Ruben Ladeira et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.